These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 35297648)

  • 61. Agreement of diagnosis and its date for hematologic malignancies and solid tumors between medicare claims and cancer registry data.
    Setoguchi S; Solomon DH; Glynn RJ; Cook EF; Levin R; Schneeweiss S
    Cancer Causes Control; 2007 Jun; 18(5):561-9. PubMed ID: 17447148
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Gonadotropin-releasing hormone agonist use in men without a cancer registry diagnosis of prostate cancer.
    Kuo YF; Goodwin JS; Shahinian VB
    BMC Health Serv Res; 2008 Jul; 8():146. PubMed ID: 18620606
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Sensitivity of Medicare claims data for measuring use of standard multiagent chemotherapy regimens.
    Lamont EB; Lan L
    Med Care; 2014 Mar; 52(3):e15-20. PubMed ID: 22410411
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Estimating Cost-effectiveness of a Multimodal Ovarian Cancer Screening Program in the United States: Secondary Analysis of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).
    Moss HA; Berchuck A; Neely ML; Myers ER; Havrilesky LJ
    JAMA Oncol; 2018 Feb; 4(2):190-195. PubMed ID: 29222541
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Patterns of use of chemotherapy for breast cancer in older women: findings from Medicare claims data.
    Du X; Goodwin JS
    J Clin Oncol; 2001 Mar; 19(5):1455-61. PubMed ID: 11230491
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Use of Medicare hospital and physician data to assess breast cancer incidence.
    Warren JL; Feuer E; Potosky AL; Riley GF; Lynch CF
    Med Care; 1999 May; 37(5):445-56. PubMed ID: 10335747
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Real-world clinical data analysis of PARPi as first-line maintenance therapy in newly diagnosed epithelial ovarian cancer patients].
    Wang DF; Zhang J; Zhang C; Yu J; Shi Y; Xu SQ; Fan Y; Zhou FZ; Song SQ; Liu H; Zhang GN
    Zhonghua Fu Chan Ke Za Zhi; 2022 Sep; 57(9):641-652. PubMed ID: 36177575
    [No Abstract]   [Full Text] [Related]  

  • 68. Evaluating algorithms for identifying incident Guillain-Barré Syndrome in Medicare fee-for-service claims.
    Eiffert SR; Wright B; Nardin J; Howard JF; Traub R
    Glob Epidemiol; 2024 Jun; 7():100145. PubMed ID: 38746856
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Measuring clinically significant chemotherapy-related toxicities using Medicare claims from Cancer and Leukemia Group B (CALGB) trial participants.
    Lamont EB; Herndon JE; Weeks JC; Henderson IC; Lilenbaum R; Schilsky RL; Christakis NA;
    Med Care; 2008 Mar; 46(3):303-8. PubMed ID: 18388845
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Costs of treatment for elderly women with advanced ovarian cancer in a Medicare population.
    Forde GK; Chang J; Ziogas A; Tewari K; Bristow RE
    Gynecol Oncol; 2015 Jun; 137(3):479-84. PubMed ID: 25866323
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Development and validation of a nomogram to predict survival outcome among epithelial ovarian cancer patients with site-distant metastases: a population-based study.
    Wang B; Wang S; Ren W
    BMC Cancer; 2021 May; 21(1):609. PubMed ID: 34034697
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Validation of an algorithm to identify incident interstitial lung disease in patients with rheumatoid arthritis.
    Meehan M; Shah A; Lobo J; Oates J; Clinton C; Annapureddy N; Xie F; Zhuo J; Danila MI; England BR; Curtis JR
    Arthritis Res Ther; 2022 Jan; 24(1):2. PubMed ID: 34980225
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Completion of adjuvant chemotherapy and use of health services for older women with epithelial ovarian cancer.
    Fairfield KM; Murray K; Lucas FL; Wierman HR; Earle CC; Trimble EL; Small L; Warren JL
    J Clin Oncol; 2011 Oct; 29(29):3921-6. PubMed ID: 21911719
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Validation of an Updated Algorithm to Identify Patients With Incident Non-Small Cell Lung Cancer in Administrative Claims Databases.
    Patel SP; Wang R; Zhou SQ; Sheinson D; Johnson A; Lee JS
    JCO Clin Cancer Inform; 2024 Mar; 8():e2300165. PubMed ID: 38502111
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Specificity and sensitivity of claims-based algorithms for identifying members of Medicare+Choice health plans that have chronic medical conditions.
    Rector TS; Wickstrom SL; Shah M; Thomas Greeenlee N; Rheault P; Rogowski J; Freedman V; Adams J; Escarce JJ
    Health Serv Res; 2004 Dec; 39(6 Pt 1):1839-57. PubMed ID: 15533190
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Measuring complications of cancer treatment using the SEER-Medicare data.
    Potosky AL; Warren JL; Riedel ER; Klabunde CN; Earle CC; Begg CB
    Med Care; 2002 Aug; 40(8 Suppl):IV-62-8. PubMed ID: 12187170
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Trends and characteristics of epithelial ovarian cancer in Japan between 2002 and 2015: A JSGO-JSOG joint study.
    Machida H; Matsuo K; Yamagami W; Ebina Y; Kobayashi Y; Tabata T; Kanauchi M; Nagase S; Enomoto T; Mikami M
    Gynecol Oncol; 2019 Jun; 153(3):589-596. PubMed ID: 30905436
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Validation of disability status, a claims-based measure of functional status for cancer treatment and outcomes studies.
    Davidoff AJ; Gardner LD; Zuckerman IH; Hendrick F; Ke X; Edelman MJ
    Med Care; 2014 Jun; 52(6):500-10. PubMed ID: 24638118
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Health Care Utilization Prior to Ovarian Cancer Diagnosis in Publicly Insured Individuals in New York State.
    Gates Kuliszewski M; Boscoe FP; Wagner VL; Schymura MJ
    J Registry Manag; 2021; 48(3):126-137. PubMed ID: 35413730
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Regional variation in cancer-directed surgery and mortality among women with epithelial ovarian cancer in the Medicare population.
    Fairfield KM; Lucas FL; Earle CC; Small L; Trimble EL; Warren JL
    Cancer; 2010 Oct; 116(20):4840-8. PubMed ID: 20578182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.